Soluble CD4: another therapeutic option in HIV infection.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D015704:CD4 Antigens / Q000008:administration & dosage / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006678:HIV / Q000378:metabolism* / Q000472:pathogenicity; D015699:HIV Envelope Protein gp120 / Q000276:immunology / Q000378:metabolism; D006801:Humans; D012995:Solubility; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000378:metabolism
D000888:Antibodies, Anti-Idiotypic; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120